PDF(810 KB)
Stathmin 2 is a potential treatment target for TDP-43 proteinopathy in amyotrophic lateral sclerosis
Yunqing Liu, Dejun Yan, Lin Yang, Xian Chen, Chun Hu, Meilan Chen
Translational Neurodegeneration ›› 2024, Vol. 13 ›› Issue (0) : 20.
PDF(810 KB)
PDF(810 KB)
Stathmin 2 is a potential treatment target for TDP-43 proteinopathy in amyotrophic lateral sclerosis
({{custom_author.role_en}}), {{javascript:window.custom_author_en_index++;}}| {{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
| 〈 |
|
〉 |